New funding

The lab has been awarded a grant from the NIH National Institute of Allergy and Infectious Diseases. This project builds on our model of IgGs binding to effector cells, to predict the effect of antibody combinations. The work is in collaboration with the Nimmerjahn lab at FAU Erlangen, and has has potential application to many diseases and therapies. As part of this funding, we will also participate in a consortium of labs working to improve antibody engineering.